免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA PMA

Coronary drug-eluting stent

PMA 核准號:P170030 · 2026-09-24

申請人Biotronik AG
決定日期2026-09-24
PMA 編號P170030
產品代碼NIQ
器械分類3 類
醫療專科U
諮詢委員會CV

器材摘要

Coronary drug-eluting stent is the device name listed in this FDA 510(k) record. The listed applicant is Biotronik AG. It received FDA 510(k) clearance on 2026-09-24. The device is classified under product code NIQ. It was reviewed by the CV advisory panel.

常見問題

What is the Coronary drug-eluting stent?

Coronary drug-eluting stent is a medical device that received FDA 510(k) clearance on 2026-09-24. The listed applicant is Biotronik AG.

When did Coronary drug-eluting stent receive FDA 510(k) clearance?

The clearance date for Coronary drug-eluting stent can be found in the official FDA records.

Who is the listed applicant for Coronary drug-eluting stent?

The FDA 510(k) record lists Biotronik AG as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Coronary drug-eluting stent?

The FDA product code for Coronary drug-eluting stent is NIQ.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑